Question · H2 2025
Tom Sykes asked for quantification of the shelf space stocking benefit expected in Q1 or Q2 in North America. He also questioned the effectiveness of Haleon's A&P spend, noting an almost 8% increase to 20% of sales while volumes are negative, asking where the A&P is ineffective versus effective, and its allocation between oral care and non-oral care businesses.
Answer
Brian McNamara, CEO, stated that Haleon would not quantify specific improvements from shelving increases but confirmed they contribute to confidence in stronger results later in the year due to increased brand visibility and shelf space. Dawn Allen, CFO, explained that A&P increased by 7.5% and R&D by 7.7% to ensure long-term sustainable growth. Half of the A&P increase went to oral health, which shows strong ROI and growth momentum. The other half was allocated to emerging markets (India, China) and expert engagement (Haleon Health Partner). Allen highlighted improvements in working/non-working media split (12% growth in working media), mid-single-digit ROI increase, and 60% of working media allocated to digital, emphasizing focus on efficiency and effectiveness.
Ask follow-up questions
Fintool can predict
HLN's earnings beat/miss a week before the call
